Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. Nanopath aims to capture specific and actionable information that respects the nuance of the underlying biology. We envision Nanopath’s platform as the go-to system for routine women’s health screening at the point-of-care. Nanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm. We aim to empower the patient and provider within the context of women’s most intimate infectious diseases and health obstacles.